Genome-Based Diagnostics: Demonstrating Clinical Utility in Oncology
Publisher: National Academies Press 2013
Number of pages: 100
Genome-Based Diagnostics assesses the evidentiary requirements for clinical utility of molecular diagnostics used to guide treatment decisions for patients with cancer; discusses methodologies related to demonstrating these evidentiary requirements that meet the needs of all stakeholders; and considers innovative, sustainable research collaborations for generating evidence of clinical utility involving multiple stakeholders.
Home page url
Download or read it online for free here:
by Richard Pazdur, at al. - CMP
The latest facts on the management of all cancers. This illustrated handbook expands on the most current techniques on screening, diagnosing, staging, prognoses, treatments, and outcomes. Written for both the clinician and patient.
- National Collaborating Centre for Cancer
These guidelines have been developed to help all those involved in the management of advanced breast cancer. The authors have tried to concentrate on those areas where it was felt uncertainty or practice variation currently exists.
by Paul J. Grippo, Hidayatullah G. Munshi - Transworld Research Network
Pancreatic adenocarcinoma is histologically characterized by a dense desmoplastic reaction surrounding malignant epithelial cells. The DR is composed of ECM proteins, fibroblasts, stellate cells, endothelial cells, immune cells, and neurons.
by Vera C. Mazurak (ed.) - MDPI AG
The development and treatment of cancer presents a complex interaction between tumor and host. The provision of nutrients provides substrates and signals for immunity, tumor metabolism and the protection of the host from treatment toxicities.